期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

对氧磷酶家族与神经系统疾病

Paraoxonase Multigene Family and Nervous System Diseases
下载PDF
导出
摘要 对氧磷酶 (paraoxonase,PON)多基因家族有 3个成员 ,包括PON1、PON2和PON3。其与疾病的关系是近 10余年来的研究热点。文章综述了PON1、PON2与神经系统常见疾病的关系及其影响。 The paraoxonase multigene family contains three members, including PON1, PON2 and PON3. The relation between them and some diseases is the focus of investigation in the last decade. The present paper mostly reviews the association between PON1/PON2 and the common diseases in nervous system as well as their influence.
作者 杨和平 赵伟佳 苏上贵
机构地区 广西医科大学附属第一医院神经内科
出处 《国外医学（脑血管疾病分册）》 2004年第9期709-713,共5页 Foreign Medical Sciences Cerebrovascular Diseases
关键词 对氧磷酶 神经系统疾病 多基因家族 常见疾病 关系 影响 综述 研究热点 paraoxonases ■ multigene family ■ nervous diseases
分类号 R741 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献42

  • 1张舒凤,孙晓江.对氧磷酶基因(PON1)启动子区T(-107)C多态性与脑梗死的相关性研究[J].中国老年学杂志,2004,24(1):4-6. 被引量：3
  • 2王晓艺,薛耀明,温淑娟,张宁玲,姬仲,潘速跃.对氧磷酶2基因C311S多态性与2型糖尿病合并缺血性脑卒中的相关性[J].中华医学遗传学杂志,2003,20(3):215-219. 被引量：13
  • 3Garin MC, James RW, Dussoix P, et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of theenzyme. A possble link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest,199
  • 4Aviram M, Hardak E, Vaya J, et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation, 2000, 101: 2510 -2517.
  • 5Aviram M, Billecke S, Sorenson R, et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human pa
  • 6Schmidt R, Schmidt H, Fazekas F, et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year followup of the austrian stroke prevention study. Arterioscler Thromb Vasc Biol, 2000, 20:1811 -1816.
  • 7Sorenson RC, Bisgaier CL, Aviram M, et al. Human serum Paraoxo nase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol, 1999,
  • 8Ng CJ, Wadleigh DJ, Gangopadhyay A, et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem, 2001, 276:44444-44449.
  • 9Draganov DI, Stetson PL, Watson CE, et al. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem,2000, 275: 33435 - 33442.
  • 10Janka Z, Juhasz A, Rimanoczy A A, et al. Codon 311 (Cys -- ＞ Ser)polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias. Mol Psychiatry, 2002, 7:110 - 112.

二级参考文献33

  • 1[1]Aviram M, Hardak E, Vaya J, et al. Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase like activities. Circulation, 2000, 30:2510
  • 2[2]McElveen J, Mackness MI, Colley CM, et al. Distribution of paraoxon hydrolitic activity in the serum of patients after myocardial infarction, Clin Chem, 1986, 32:671
  • 3[3]Mackness MI, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis, 1991, 86:193
  • 4[4]Furlong CE, Richter RJ, Seidel SL, et al. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolisis of the insecticide metabolites chlorpyifos oxon and paraoxon. Am J Hum Genet, 1988, 43:230
  • 5[5]Steinberg D. Lipoproteins and atherosclerosis:a look back and a look ahead. Arteriosclerosis, 1983, 3:283
  • 6[6]Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol:Modification of low-density lipoprotein that increase its atherogenicity. New England J Medicine, 1989, 320(14):915
  • 7[7]Gordon D. In:Durrington PN(ed). HDL:Where should the clinician stand? London:Mark Allen Publishing, 1992,17
  • 8[8]Klimov AN, Kozhemyakin LA, Pleskov VM, et al. Antioxidative effect of high density lipoprotein in the oxidation of low density lipoprotein. Bull Exp Biol Med, 1987, 103:550
  • 9[9]Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high-density lipoprotein (HDL) oxidation and preserves its functions. J Clin Invest, 1998, 101:1581
  • 10[10]Mackness B, Mackness MI, Arol S, et al. Effect of human serum paraoxonase 55 and 192 genetic polymorphism on the protection by high density lipoprotein oxidative modification. FEBS Lett, 1998, 423(1):57

共引文献16

国外医学（脑血管疾病分册）
2004年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部